Viewing Study NCT00534118

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-03-06 @ 1:48 PM
Study NCT ID: NCT00534118
Status: COMPLETED
Last Update Posted: 2020-08-26
First Post: 2007-09-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Sponsor: Roswell Park Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Multiple Myeloma and Plasma Cell Neoplasm View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None accelerated phase chronic myelogenous leukemia View
None chronic phase chronic myelogenous leukemia View
None relapsing chronic myelogenous leukemia View
None childhood chronic myelogenous leukemia View
None previously treated myelodysplastic syndromes View
None recurrent adult acute lymphoblastic leukemia View
None recurrent childhood acute lymphoblastic leukemia View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None recurrent adult acute myeloid leukemia View
None recurrent childhood acute myeloid leukemia View
None stage I multiple myeloma View
None stage II multiple myeloma View
None stage III multiple myeloma View
None refractory multiple myeloma View
None recurrent adult Hodgkin lymphoma View
None recurrent/refractory childhood Hodgkin lymphoma View
None recurrent adult Burkitt lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent mantle cell lymphoma View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None recurrent adult grade III lymphomatoid granulomatosis View
None Waldenstrom macroglobulinemia View
None recurrent childhood grade III lymphomatoid granulomatosis View
None recurrent childhood large cell lymphoma View
None recurrent childhood lymphoblastic lymphoma View
None childhood diffuse large cell lymphoma View
None childhood immunoblastic large cell lymphoma View
None recurrent childhood small noncleaved cell lymphoma View
None de novo myelodysplastic syndromes View
None secondary acute myeloid leukemia View
None secondary myelodysplastic syndromes View
None splenic marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None recurrent mycosis fungoides/Sezary syndrome View
None cutaneous B-cell non-Hodgkin lymphoma View